409 related articles for article (PubMed ID: 20109233)
21. Complement components are upregulated and correlate with disease progression in the TDP-43
Lee JD; Levin SC; Willis EF; Li R; Woodruff TM; Noakes PG
J Neuroinflammation; 2018 Jun; 15(1):171. PubMed ID: 29859100
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis.
Watanabe-Matsumoto S; Moriwaki Y; Okuda T; Ohara S; Yamanaka K; Abe Y; Yasui M; Misawa H
Neurosci Res; 2018 Aug; 133():48-57. PubMed ID: 29154923
[TBL] [Abstract][Full Text] [Related]
23. Acute glial activation by stab injuries does not lead to overt damage or motor neuron degeneration in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis.
Suzuki M; Klein S; Wetzel EA; Meyer M; McHugh J; Tork C; Hayes A; Svendsen CN
Exp Neurol; 2010 Feb; 221(2):346-52. PubMed ID: 20005223
[TBL] [Abstract][Full Text] [Related]
24. The review of the methods to obtain non-neuronal cells to study glial influence on Amyotrophic Lateral Sclerosis pathophysiology at molecular level in vitro.
Scorisa JM; Duobles T; Oliveira GP; Maximino JR; Chadi G
Acta Cir Bras; 2010 Jun; 25(3):281-9. PubMed ID: 20498942
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of insulin-like growth factor-II receptor in reactive astrocytes in the spinal cord of amyotrophic lateral sclerosis transgenic rats.
Dagvajantsan B; Aoki M; Warita H; Suzuki N; Itoyama Y
Tohoku J Exp Med; 2008 Apr; 214(4):303-10. PubMed ID: 18441505
[TBL] [Abstract][Full Text] [Related]
26. In Vivo imaging reveals distinct inflammatory activity of CNS microglia versus PNS macrophages in a mouse model for ALS.
Dibaj P; Steffens H; Zschüntzsch J; Nadrigny F; Schomburg ED; Kirchhoff F; Neusch C
PLoS One; 2011 Mar; 6(3):e17910. PubMed ID: 21437247
[TBL] [Abstract][Full Text] [Related]
27. Protein-bound crotonaldehyde accumulates in the spinal cord of superoxide dismutase-1 mutation-associated familial amyotrophic lateral sclerosis and its transgenic mouse model.
Shibata N; Kawaguchi M; Uchida K; Kakita A; Takahashi H; Nakano R; Fujimura H; Sakoda S; Ihara Y; Nobukuni K; Takehisa Y; Kuroda S; Kokubo Y; Kuzuhara S; Honma T; Mochizuki Y; Mizutani T; Yamada S; Toi S; Sasaki S; Iwata M; Hirano A; Yamamoto T; Kato Y; Sawada T; Kobayashi M
Neuropathology; 2007 Feb; 27(1):49-61. PubMed ID: 17319283
[TBL] [Abstract][Full Text] [Related]
28. Increased ceruloplasmin expression caused by infiltrated leukocytes, activated microglia, and astrocytes in injured female rat spinal cords.
Wu Y; Shen L; Wang R; Tang J; Ding SQ; Wang SN; Guo XY; Hu JG; Lü HZ
J Neurosci Res; 2018 Jul; 96(7):1265-1276. PubMed ID: 29377294
[TBL] [Abstract][Full Text] [Related]
29. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
30. Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells.
Keller AF; Gravel M; Kriz J
Glia; 2009 Aug; 57(10):1130-42. PubMed ID: 19115383
[TBL] [Abstract][Full Text] [Related]
31. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression.
Tortarolo M; Veglianese P; Calvaresi N; Botturi A; Rossi C; Giorgini A; Migheli A; Bendotti C
Mol Cell Neurosci; 2003 Jun; 23(2):180-92. PubMed ID: 12812752
[TBL] [Abstract][Full Text] [Related]
32. Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis.
Tada S; Okuno T; Yasui T; Nakatsuji Y; Sugimoto T; Kikutani H; Sakoda S
J Neuroinflammation; 2011 Feb; 8():19. PubMed ID: 21345177
[TBL] [Abstract][Full Text] [Related]
33. Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis.
Bowerman M; Salsac C; Coque E; Eiselt É; Deschaumes RG; Brodovitch A; Burkly LC; Scamps F; Raoul C
Hum Mol Genet; 2015 Jun; 24(12):3440-56. PubMed ID: 25765661
[TBL] [Abstract][Full Text] [Related]
34. Intrathecal infusion of BMAA induces selective motor neuron damage and astrogliosis in the ventral horn of the spinal cord.
Yin HZ; Yu S; Hsu CI; Liu J; Acab A; Wu R; Tao A; Chiang BJ; Weiss JH
Exp Neurol; 2014 Nov; 261():1-9. PubMed ID: 24918341
[TBL] [Abstract][Full Text] [Related]
35. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
[TBL] [Abstract][Full Text] [Related]
36. Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene.
Fendrick SE; Xue QS; Streit WJ
J Neuroinflammation; 2007 Feb; 4():9. PubMed ID: 17328801
[TBL] [Abstract][Full Text] [Related]
37. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.
Butovsky O; Siddiqui S; Gabriely G; Lanser AJ; Dake B; Murugaiyan G; Doykan CE; Wu PM; Gali RR; Iyer LK; Lawson R; Berry J; Krichevsky AM; Cudkowicz ME; Weiner HL
J Clin Invest; 2012 Sep; 122(9):3063-87. PubMed ID: 22863620
[TBL] [Abstract][Full Text] [Related]
38. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Almer G; Vukosavic S; Romero N; Przedborski S
J Neurochem; 1999 Jun; 72(6):2415-25. PubMed ID: 10349851
[TBL] [Abstract][Full Text] [Related]
39. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis.
Dunlop J; Beal McIlvain H; She Y; Howland DS
J Neurosci; 2003 Mar; 23(5):1688-96. PubMed ID: 12629173
[TBL] [Abstract][Full Text] [Related]
40. Dynamics of microglial activation in the spinal cord after cerebral infarction are revealed by expression of MHC class II antigen.
Schmitt AB; Brook GA; Buss A; Nacimiento W; Noth J; Kreutzberg GW
Neuropathol Appl Neurobiol; 1998 Jun; 24(3):167-76. PubMed ID: 9717181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
